GW806742X

CHF 108.00
In stock
SYN-1215-M0011 mgCHF 108.00
SYN-1215-M0055 mgCHF 227.00
SYN-1215-M01010 mgCHF 383.00
SYN-1215-M05050 mgCHF 1'017.00
SYN-1215-M100100 mgCHF 1'736.00
 
More Information
Product Details
Synonyms AC1NS7PT; AGN-PC-0LQ49Y
Product Type Chemical
Properties
Formula C25H22F3N7O4S
MW 573.6
CAS 579515-63-2
Purity Chemicals ≥95%
Appearance Solid.
Solubility Soluble in DMSO.
Declaration Manufactured by SynKinase.
Other Product Data Target: VEGFR2/YES/MLKL | Kinase Group: RTK | Substrate: Tyrosine

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.
InChi Key SNRUTMWCDZHKKM-UHFFFAOYSA-N
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS Download PDF
Product Specification Sheet
Datasheet Download PDF
Potent protein kinase VEGFR2 inhibitor (2nm range). Binds to the pseudokinase domain of MLKL and blocks cell death by necroptosis, as well. With regards to its role in necroptosis, it is an ATP-mimetic that was shown to bind recombinant mouse MLKL pseudokinase domain, which showed inhibited TSQ-induced death of mouse dermal fibroblasts by delaying MLKL translocation to the membrane. Appears therefore to be a valuable reagent to inhibit necroptosis. It also provides an important proof-of-principle that targeting catalytically-dead pseudoenzymes represents a feasible, emerging therapeutic avenue.
Product References
  1. Discovery of a novel and potent series of dianilinopyrimidineurea and urea isostere inhibitors of VEGFR2 tyrosine kinase: D.M. Sammond, et al.; Bioorg. Med. Chem Lett. 15, 3519 (2005)
  2. Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death: J.M. Hildebrand, et al.; PNAS 111, 15072 (2014)
  3. Identification and structure-function analysis of subfamily selective G protein-coupled receptor kinase inhibitors: K.T. Homan, et al.; ACS Chem. Biol. 10, 310 (2015)
  4. Neutrophil necroptosis is triggered by ligation of adhesion molecules following GM-CSF priming: X. Wang, et al.; J. Immunol. 197, 4090 (2016)
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.